Study Start-Up

Expert Meetings

Overview

Study start-up (SSU) for randomized controlled trials is usually a long and costly process that can cause significant delays.  

Addressing this challenge, CTTI conducted work to identify specific metrics and benchmarks related to SSU, recommending greater standardization within the clinical trials ecosystem. More recently, it also conducted research and released report showing that budgets and contracts are significant contributors to delays, laying the groundwork for future industry work on remodeling the SSU process. 

Solutions

Search All

News

Case Study

    In Detail